Myrexis Announces Corporate Reorganization to Focus on Development Objectives
November 18, 2011 11:45 ET
|
Myrexis, Inc.
Internal Resources Realigned to Support Development Strategy
Further 20% Reduction in Workforce and $1.8 Million in Annual Cost Reduction
SALT LAKE CITY, Nov. 18, 2011 (GLOBE NEWSWIRE) --...
Myrexis Presents at 2011 EORTC/NCI/AACR Molecular Targets and Cancer Therapeutics Symposium
November 14, 2011 09:05 ET
|
Myrexis, Inc.
SALT LAKE CITY, Nov. 14, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule therapeutics with novel chemical structures and...
Myrexis Reports First Quarter Fiscal Year 2012 Results
November 09, 2011 16:11 ET
|
Myrexis, Inc.
SALT LAKE CITY, Nov. 9, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule therapeutics with novel chemical structures and...
CORRECTION -- Myrexis to Hold Conference Call to Discuss First Quarter 2012 Financial Results
November 03, 2011 18:03 ET
|
Myrexis, Inc.
SALT LAKE CITY, Nov. 3, 2011 (GLOBE NEWSWIRE) -- In a press release issued earlier today by Myrexis, Inc. (Nasdaq:MYRX) with the same headline, please note that the conference call will be held on...
Myrexis to Hold Conference Call to Discuss First Quarter 2012 Financial Results
November 03, 2011 16:02 ET
|
Myrexis, Inc.
SALT LAKE CITY, Nov. 3, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule therapeutics with novel chemical structures and...
Myrexis to Present at 2011 EORTC/NCI/AACR Molecular Targets and Cancer Therapeutics Symposium
November 03, 2011 16:02 ET
|
Myrexis, Inc.
SALT LAKE CITY, Nov. 3, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule therapeutics with novel chemical structures and...
Myrexis Appoints Jason M. Aryeh to its Board of Directors
October 20, 2011 16:37 ET
|
Myrexis, Inc.
SALT LAKE CITY, Oct. 20, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule therapeutics with novel chemical structures and...
Myrexis to Participate in the 2011 UBS Global Life Sciences Conference
September 14, 2011 16:00 ET
|
Myrexis, Inc.
SALT LAKE CITY, Sept. 14, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule compounds with novel chemical structures and...
Myrexis to Present at 2011 Rodman and Renshaw Healthcare Conference
September 09, 2011 09:29 ET
|
Myrexis, Inc.
SALT LAKE CITY, Sept. 9, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule compounds with novel chemical structures and...
Myrexis Reports Fourth Quarter and Fiscal Year 2011 Results
September 08, 2011 16:02 ET
|
Myrexis, Inc.
Clinical Development Strategy Update
Conference Call Today at 4:30 pm EDT
SALT LAKE CITY, Sept. 8, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the...